Search research articles
Contact Us
Filters
Showing results (101-110 of 179) with videos related to
Page
of 18
Sort By:
Blood Cells, Molecules & Diseases
|
August 3, 2001
Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes
A P Rapoport, M Simons-Evelyn, T Chen, et al.
Cancer
|
February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2
James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients
Naoko Takebe, Xiangfei Cheng, Suhlan Wu, et al.
Bone Marrow Transplantation
|
April 1, 1995
Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years
A P Rapoport, J F DiPersio, B A Martin, et al.
Bone Marrow Transplantation
|
February 2, 2016
Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
J A Yared, N Hardy, Z Singh, et al.
Cancer
|
December 4, 2014
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study
Vishal Bhatnagar, Yin Wu, Olga G Goloubeva, et al.
Journal for Immunotherapy of Cancer
|
July 19, 2022
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine
Djordje Atanackovic, Robert J Kreitman, Jeffrey Cohen, et al.
Bone Marrow Transplantation
|
June 17, 2018
Final outcomes of escalated melphalan 280 mg/m<sup>2</sup> with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
Parameswaran Hari, Donna E Reece, Jasleen Randhawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2009
Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy
Merry Y Zhao, Aaron Auerbach, Anisha M D'Costa, et al.
American Journal of Hematology
|
July 26, 2019
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss
Ali Bukhari, Firas El Chaer, Rima Koka, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 179) with videos related to
Sort By:
Page
of 18
Blood Cells, Molecules & Diseases
|
August 3, 2001
Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes
A P Rapoport, M Simons-Evelyn, T Chen, et al.
Cancer
|
February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2
James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients
Naoko Takebe, Xiangfei Cheng, Suhlan Wu, et al.
Bone Marrow Transplantation
|
April 1, 1995
Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years
A P Rapoport, J F DiPersio, B A Martin, et al.
Bone Marrow Transplantation
|
February 2, 2016
Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
J A Yared, N Hardy, Z Singh, et al.
Cancer
|
December 4, 2014
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study
Vishal Bhatnagar, Yin Wu, Olga G Goloubeva, et al.
Journal for Immunotherapy of Cancer
|
July 19, 2022
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine
Djordje Atanackovic, Robert J Kreitman, Jeffrey Cohen, et al.
Bone Marrow Transplantation
|
June 17, 2018
Final outcomes of escalated melphalan 280 mg/m<sup>2</sup> with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
Parameswaran Hari, Donna E Reece, Jasleen Randhawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2009
Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy
Merry Y Zhao, Aaron Auerbach, Anisha M D'Costa, et al.
American Journal of Hematology
|
July 26, 2019
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss
Ali Bukhari, Firas El Chaer, Rima Koka, et al.
Page
of 18